Menendez JA et al. |
Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites. |
2014 |
Cell Cycle |
pmid:24526120
|
Durán RV and Hall MN |
Glutaminolysis feeds mTORC1. |
2012 |
Cell Cycle |
pmid:23095634
|
Kato Kaneko M et al. |
Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of bone. |
2014 |
Cancer Sci. |
pmid:24898068
|
Emir UE et al. |
Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations. |
2016 |
Cancer Res. |
pmid:26669865
|
Izquierdo-Garcia JL et al. |
IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism. |
2015 |
Cancer Res. |
pmid:26045167
|
Jin G et al. |
Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas. |
2013 |
Cancer Res. |
pmid:23204232
|
Seltzer MJ et al. |
Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. |
2010 |
Cancer Res. |
pmid:21045145
|
Liesenfeld DB et al. |
Aspirin Reduces Plasma Concentrations of the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover Trial. |
2016 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:26585118
|
Shim EH et al. |
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer. |
2014 |
Cancer Discov |
pmid:25182153
|
Elhammali A et al. |
A high-throughput fluorimetric assay for 2-hydroxyglutarate identifies Zaprinast as a glutaminase inhibitor. |
2014 |
Cancer Discov |
pmid:24740997
|
Cairns RA and Mak TW |
Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities. |
2013 |
Cancer Discov |
pmid:23796461
|
Macaulay RJ |
Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas. |
2015 |
Cancer Control |
pmid:26068765
|
Tateishi K et al. |
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion. |
2015 |
Cancer Cell |
pmid:26678339
|
Xu W et al. |
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. |
2011 |
Cancer Cell |
pmid:21251613
|
Figueroa ME et al. |
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. |
2010 |
Cancer Cell |
pmid:21130701
|
Ward PS et al. |
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. |
2010 |
Cancer Cell |
pmid:20171147
|
Frezza C et al. |
IDH1 mutations in gliomas: when an enzyme loses its grip. |
2010 |
Cancer Cell |
pmid:20129244
|
Farias FH et al. |
A L2HGDH initiator methionine codon mutation in a Yorkshire terrier with L-2-hydroxyglutaric aciduria. |
2012 |
BMC Vet. Res. |
pmid:22834903
|
Khorassani R et al. |
Citramalic acid and salicylic acid in sugar beet root exudates solubilize soil phosphorus. |
2011 |
BMC Plant Biol. |
pmid:21871058
|
Tai H and Zhang Z |
A novel compound heterozygous mutation in a Chinese boy with L-2-hydroxyglutaric aciduria: a case study. |
2015 |
BMC Neurol |
pmid:26208971
|
Calduch-Giner JA et al. |
Use of microarray technology to assess the time course of liver stress response after confinement exposure in gilthead sea bream (Sparus aurata L.). |
2010 |
BMC Genomics |
pmid:20307314
|
Butler JE et al. |
Genomic and microarray analysis of aromatics degradation in Geobacter metallireducens and comparison to a Geobacter isolate from a contaminated field site. |
2007 |
BMC Genomics |
pmid:17578578
|
Jansen EE et al. |
Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development. |
2008 |
BMC Dev. Biol. |
pmid:19040727
|
Wang Y and Zhang YH |
Cell-free protein synthesis energized by slowly-metabolized maltodextrin. |
2009 |
BMC Biotechnol. |
pmid:19558718
|
Van Deun K et al. |
A structured overview of simultaneous component based data integration. |
2009 |
BMC Bioinformatics |
pmid:19671149
|
Keum YS and Choi BY |
Isocitrate dehydrogenase mutations: new opportunities for translational research. |
2015 |
BMB Rep |
pmid:25787993
|
Shi X et al. |
Functions of idh1 and its mutation in the regulation of developmental hematopoiesis in zebrafish. |
2015 |
Blood |
pmid:25778530
|
Reitman ZJ et al. |
Genetic dissection of leukemia-associated IDH1 and IDH2 mutants and D-2-hydroxyglutarate in Drosophila. |
2015 |
Blood |
pmid:25398939
|
DiNardo CD et al. |
Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia. |
2013 |
Blood |
pmid:23641016
|
Fathi AT et al. |
Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response. |
2012 |
Blood |
pmid:23074281
|
Cairns RA et al. |
IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. |
2012 |
Blood |
pmid:22215888
|
Amatangelo MD et al. |
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response. |
2017 |
Blood |
pmid:28588019
|
Li Y et al. |
Combined inactivation of the Clostridium cellulolyticum lactate and malate dehydrogenase genes substantially increases ethanol yield from cellulose and switchgrass fermentations. |
2012 |
Biotechnol Biofuels |
pmid:22214220
|
Fernández-Briera A and Garrido-Pertierra A |
A degradation pathway of propionate in Salmonella typhimurium LT-2. |
1988 |
Biochimie |
pmid:2844305
|
Riedel TJ et al. |
4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition. |
2012 |
Biochim. Biophys. Acta |
pmid:22771891
|
Kranendijk M et al. |
A lymphoblast model for IDH2 gain-of-function activity in d-2-hydroxyglutaric aciduria type II: novel avenues for biochemical and therapeutic studies. |
2011 |
Biochim. Biophys. Acta |
pmid:21889589
|
da Silva CG et al. |
Inhibition of cytochrome c oxidase activity in rat cerebral cortex and human skeletal muscle by D-2-hydroxyglutaric acid in vitro. |
2002 |
Biochim. Biophys. Acta |
pmid:11781152
|
Parthasarathy A et al. |
Substrate specificity of 2-hydroxyglutaryl-CoA dehydratase from Clostridium symbiosum: toward a bio-based production of adipic acid. |
2011 |
Biochemistry |
pmid:21434666
|
Roymoulik I et al. |
Rearrangement of L-2-hydroxyglutarate to L-threo-3-methylmalate catalyzed by adenosylcobalamin-dependent glutamate mutase. |
2000 |
Biochemistry |
pmid:10956023
|
Achouri Y et al. |
Identification of a dehydrogenase acting on D-2-hydroxyglutarate. |
2004 |
Biochem. J. |
pmid:15070399
|
Constantin A et al. |
Identifying malignant transformations in recurrent low grade gliomas using high resolution magic angle spinning spectroscopy. |
2012 |
Artif Intell Med |
pmid:22387185
|
González R et al. |
Growth and final product formation by Bifidobacterium infantis in aerated fermentations. |
2004 |
Appl. Microbiol. Biotechnol. |
pmid:15085297
|
van der Knaap MS et al. |
D-2-Hydroxyglutaric aciduria: biochemical marker or clinical disease entity? |
1999 |
Ann. Neurol. |
pmid:9894884
|
Pichumani K et al. |
Conditions for (13)C NMR detection of 2-hydroxyglutarate in tissue extracts from isocitrate dehydrogenase-mutated gliomas. |
2015 |
Anal. Biochem. |
pmid:25908561
|
Işıkay S et al. |
A child with L-2 hydroxyglutaric aciduria presenting with dilated cardiomyopathy: coincidence or a new syndrome? |
2014 |
Anadolu Kardiyol Derg |
pmid:24382499
|
Hwang VJ et al. |
The cpk model of recessive PKD shows glutamine dependence associated with the production of the oncometabolite 2-hydroxyglutarate. |
2015 |
Am. J. Physiol. Renal Physiol. |
pmid:26155843
|
Nota B et al. |
Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria. |
2013 |
Am. J. Hum. Genet. |
pmid:23561848
|
Struys EA et al. |
Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria. |
2005 |
Am. J. Hum. Genet. |
pmid:15609246
|
Fathi AT and Abdel-Wahab O |
Mutations in epigenetic modifiers in myeloid malignancies and the prospect of novel epigenetic-targeted therapy. |
2012 |
Adv Hematol |
pmid:21811504
|
Bleeker FE et al. |
The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma. |
2010 |
Acta Neuropathol. |
pmid:20127344
|